Holen Sie sich die Stockscreener-App
0.7859
1.70%
0.0131
Handel nachbörslich:
.79
0.0041
+0.52%
Schlusskurs vom Vortag:
$0.7728
Offen:
$0.77
24-Stunden-Volumen:
689.51K
Relative Volume:
0.60
Marktkapitalisierung:
$101.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.91M
KGV:
-3.5723
EPS:
-0.22
Netto-Cashflow:
$-19.57M
1W Leistung:
-0.24%
1M Leistung:
-16.26%
6M Leistung:
-3.57%
1J Leistung:
-39.55%
1-Tages-Spanne:
$0.7622
$0.7973
1-Wochen-Bereich:
$0.755
$0.807
52-Wochen-Spanne:
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
Firmenname
Atossa Therapeutics Inc
Sektor
Branche
Telefon
206.588.0256
Adresse
10202 5TH AVENUE NE, SEATTLE, WA
Vergleichen Sie ATOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.7859 | 99.82M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-01-26 | Eingeleitet | Maxim Group | Buy |
Atossa Therapeutics Inc Aktie (ATOS) Neueste Nachrichten
Should you wait for a breakout in Atossa Therapeutics Inc.July 2025 Reactions & Capital Efficient Trading Techniques - Newser
Technical analysis overview for Atossa Therapeutics Inc. stockJuly 2025 Pullbacks & Low Drawdown Investment Strategies - Newser
Ranking Atossa Therapeutics Inc. among high performing stocks via toolsTrade Analysis Summary & AI Optimized Trade Strategies - Newser
What recovery options are there for Atossa Therapeutics Inc.CEO Change & Growth Oriented Trading Recommendations - Newser
Atossa Therapeutics Advances Breast Cancer Treatments - TipRanks
What does recent volatility data suggest for Atossa Therapeutics Inc. [July 2025 News Drivers]Weekly Breakout Opportunity Watchlist - Newser
Can momentum traders help lift Atossa Therapeutics Inc.Short-Term Price Breakout Signal Analysis - Newser
Atossa Therapeutics Inc. stock momentum explainedDaily Breakout List with Smart Filters - Newser
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Applying sector rotation models to Atossa Therapeutics Inc. [July 2025 Rallies]Risk Controlled Stock Pick Alerts - Newser
Leading vs lagging indicators on Atossa Therapeutics Inc. performanceHigh Probability Trade Outcome Prediction - Newser
Why Atossa Therapeutics Inc. stock attracts strong analyst attentionPortfolio Review Summary with Five-Year Outlook - Newser
Short Term Charts Align With Long Term Uptrend in Atossa Therapeutics Inc.Growth Based Stock Signal Screener Updated - 선데이타임즈
Atossa Therapeutics' Q2 2025 Earnings: Navigating Financial Losses and the Promise of (Z)-endoxifen in Metastatic Breast Cancer - AInvest
Atossa Therapeutics Q2 2025 Financial Results and Corporate Update - TradingView
FDA Fast-Tracks Atossa's Breast Cancer Drug as Clinical Trial Shows 77% Tumor Reduction - Stock Titan
Risk vs reward if holding onto Atossa Therapeutics Inc.Free Pattern Alert With ROI Driven Strategy - Newser
What the charts say about Atossa Therapeutics Inc. todayAI Model Forecasting Reversal and Breakout Zones - Newser
Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update - Ariva
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pensacola News Journal
How moving averages guide Atossa Therapeutics Inc. tradingEquity Market Return Forecast Model Update - Newser
New Product Launches: Will They Boost Atossa Therapeutics Inc. Stock in 2025Free Sector Rotation Based Trading Opportunities - Newser
What makes Atossa Therapeutics Inc. stock price move sharplyFree Growth Based Stock Signal Screener - Newser
Is Atossa Therapeutics Inc. building a consolidation baseTrade Signal Summary & Consistent Profit Trade Alerts - Newser
What does recent volatility data suggest for Atossa Therapeutics Inc.Secure Trading Strategy Based on Technical Analysis - Newser
Atossa Therapeutics Inc. Uptrend in Early Stages Indicators Say YesReversal Alert Based on RSI Indicator Confirmed - beatles.ru
Published on: 2025-08-09 01:47:05 - Newser
Does Atossa Therapeutics Inc. show high probability of reboundFree Consistent Gain Investment Strategies - Newser
Atossa Genetics (ATOS) Expected to Announce Earnings on Monday - Defense World
Will Atossa Therapeutics Inc. benefit from macro trendsLow Drawdown Stock Screener with Analysis - Newser
Atossa Therapeutics Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Published on: 2025-08-05 01:42:52 - Newser
Published on: 2025-08-04 22:41:33 - Newser
Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4 - 富途牛牛
Is Atossa Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis Inside - Newser
Should I hold or sell Atossa Therapeutics Inc. stock in 2025Build a diversified portfolio for risk mitigation - Jammu Links News
What analysts say about Atossa Therapeutics Inc. stockAchieve breakthrough investment performance - Jammu Links News
When is Atossa Therapeutics Inc. stock expected to show significant growthExceptional gains - Jammu Links News
What is the risk reward ratio of investing in Atossa Therapeutics Inc. stockTrack top-performing stocks in real-time - Jammu Links News
Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):